MedWatch

Pharma giants agree: Clinical research in Denmark is too expensive

The Danish divisions at a number of the world's largest pharmaceutical companies now join in on Roche's recent criticism of the conditions for conducting clinical research in Denmark. "I think that the pharmaceutical industry in Denmark knows that we are working hard to create the best conditions," responds Danish Minister Ellen Trane Nørby.

Foto: Labflex / PR

It caused a stir last week when Roche came out with harsh criticism of the conditions that international pharmaceutical companies operate under when conducting clinical research in Denmark.

A sudden and large rise in fees and different practices between regions and even between hospitals within the same region were among Roche's criticisms. The criticism was backed by several industry representatives, who believe that it is a threat to future research in Denmark.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier